TREANDA (BENDAMUSTINE HCI) FOR INJECTION Trademark

Trademark Overview

On Thursday, October 10, 2013, a trademark application was filed for TREANDA (BENDAMUSTINE HCI) FOR INJECTION with the United States Patent and Trademark Office. The USPTO has given the TREANDA (BENDAMUSTINE HCI) FOR INJECTION trademark a serial number of 86088292. The federal status of this trademark filing is SECTION 8 & 15 - ACCEPTED AND ACKNOWLEDGED as of Tuesday, September 14, 2021. This trademark is owned by Cephalon, Inc.. The TREANDA (BENDAMUSTINE HCI) FOR INJECTION trademark is filed in the Paper & Printed Material Products category with the following description:

Pamphlets and brochures containing information regarding the treatment of cancer
treanda (bendamustine hci) for injection

General Information

Serial Number86088292
Word MarkTREANDA (BENDAMUSTINE HCI) FOR INJECTION
Filing DateThursday, October 10, 2013
Status702 - SECTION 8 & 15 - ACCEPTED AND ACKNOWLEDGED
Status DateTuesday, September 14, 2021
Registration Number4696840
Registration DateTuesday, March 3, 2015
Mark Drawing3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, May 13, 2014

Trademark Statements

Description of MarkThe mark consists of the black word "TREANDA" and the black words "BENDAMUSTINE HCI" written in black brackets and the black words "FOR INJECTION" written outside the brackets with design of two green and purple eyebrows on the left side of the mark.
Amendment to a Registration/Renewal CertificateThe drawing is amended to appear as follows: PUBLISH NEW CUT and in the statement, line 10, "Liquid Formulation" is deleted. In the statement, line 11 is deleted and " "BENDAMUSTINE HCI", ""FOR INJECTION"" is inserted. In the statement, lines 12 thru 16 are deleted, and "The mark consists of the black word TREANDA and the black words BENDAMUSTINE HCI written in black brackets and the black words FOR INJECTION written outside the brackets with design of two green and purple eyebrows on the left side of the mark." is inserted.
Goods and ServicesPamphlets and brochures containing information regarding the treatment of cancer
Indication of Colors claimedThe color(s) Purple, green and black is/are claimed as a feature of the mark.
NOT AVAILABLE"BENDAMUSTINE HCI", "FOR INJECTION"

Classification Information

International Class016 - Paper, cardboard and goods made from these materials, not included in other classes; printed matter; bookbinding material; photographs; stationery; adhesives for stationery or household purposes; artists' materials; paint brushes; typewriters and office requisites (except furniture); instructional and teaching material (except apparatus); plastic materials for packaging (not included in other classes); printers' type; printing blocks.
US Class Codes002, 005, 022, 023, 029, 037, 038, 050
Class Status Code6 - Active
Class Status DateFriday, October 18, 2013
Primary Code016
First Use Anywhere DateMonday, November 17, 2014
First Use In Commerce DateMonday, November 17, 2014

Trademark Owner History

Party NameCEPHALON LLC
Party Type31 - New Owner After Registration
Legal Entity Type16 - Limited Liability Company
AddressWEST CHESTER, PA 19380
Party NameCephalon, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressWest Chester, PA 19380
Party NameCephalon, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressFrazer, PA 19355
Party NameCephalon, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressFrazer, PA 19355

Trademark Events

Event DateEvent Description
Monday, February 3, 2014NON-FINAL ACTION WRITTEN
Monday, October 14, 2013NEW APPLICATION ENTERED
Friday, October 18, 2013NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Saturday, October 19, 2013NOTICE OF DESIGN SEARCH CODE E-MAILED
Monday, January 27, 2014ASSIGNED TO EXAMINER
Monday, February 3, 2014NON-FINAL ACTION E-MAILED
Monday, February 3, 2014NOTIFICATION OF NON-FINAL ACTION E-MAILED
Saturday, April 5, 2014LAW OFFICE PUBLICATION REVIEW COMPLETED
Tuesday, May 13, 2014PUBLISHED FOR OPPOSITION
Monday, March 10, 2014TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, March 10, 2014CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, March 10, 2014TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, March 17, 2014APPROVED FOR PUB - PRINCIPAL REGISTER
Saturday, April 5, 2014ASSIGNED TO LIE
Wednesday, April 23, 2014NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, March 3, 2015REGISTERED-PRINCIPAL REGISTER
Tuesday, March 3, 2020COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Tuesday, May 13, 2014OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, July 8, 2014NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Monday, December 1, 2014TEAS STATEMENT OF USE RECEIVED
Monday, December 1, 2014USE AMENDMENT FILED
Tuesday, January 13, 2015STATEMENT OF USE PROCESSING COMPLETE
Monday, January 12, 2015CASE ASSIGNED TO INTENT TO USE PARALEGAL
Thursday, January 29, 2015ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Friday, January 30, 2015NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Wednesday, March 3, 2021TEAS SECTION 8 & 15 RECEIVED
Wednesday, July 14, 2021APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Wednesday, March 3, 2021TEAS SECTION 7 REQUEST RECEIVED
Tuesday, July 13, 2021CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Tuesday, July 13, 2021POST REGISTRATION ACTION MAILED - SEC. 7
Wednesday, July 14, 2021TEAS CHANGE OF OWNER ADDRESS RECEIVED
Wednesday, July 14, 2021TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Wednesday, July 14, 2021TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, July 14, 2021ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, July 14, 2021TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, September 14, 2021AMENDMENT UNDER SECTION 7 - PROCESSED
Wednesday, March 27, 2024TEAS SECTION 8 & 9 RECEIVED
Thursday, September 9, 2021TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED
Tuesday, September 14, 2021REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Tuesday, September 14, 2021NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
Wednesday, December 7, 2022AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Sunday, March 3, 2024COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
Thursday, June 27, 2024CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Thursday, June 27, 2024POST REGISTRATION ACTION MAILED - SEC. 8 & 9
Friday, February 14, 2025TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED
Sunday, February 16, 2025POST REGISTRATION ACTION MAILED - SEC. 8 & 9
Sunday, September 28, 2025CANCELLED SEC. 8 (10-YR)

Related Keywords

injection bendamustine treanda treatment cancer regarding information brochures containing pamphlets